Christopher McGhee
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Internal Medicine top 10%
Papers in
-
- COVID-19 Clinical Research Studies 12
-
- Cardiac Arrest and Resuscitation 3
- Co-authors
- Maciej Tadeusz Juszczak (1 shared paper)Jelle Michiel Zuidam (2 shared papers)Liron S. Duraku (3 shared papers)Caroline Anna Hundepool (1 shared paper)Dominic Power (5 shared papers)Mark J.W. van der Oest (1 shared paper)Christina Jerosch‐Herold (1 shared paper)Caroline Miller (2 shared papers)
- Journals
- JAMA (8 papers)The Lancet (6 papers)Intensive Care Medicine (3 papers)Nature (2 papers)Intensive Care Medicine Experimental (1 paper)
- Partner nations
- United KingdomNetherlandsVietnam
In The Last Decade
Christopher McGhee
25 papers receiving 2.8k citations
Christopher McGhee's Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 1.7k
- Internal Medicine 49
- Pulmonary and Respiratory Medicine 467
- Applied Microbiology and Biotechnology 35
- Emergency Medicine 85
Countries citing papers authored by Christopher McGhee
This map shows the geographic impact of Christopher McGhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McGhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McGhee more than expected).
Fields of papers citing papers by Christopher McGhee
This network shows the impact of papers produced by Christopher McGhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McGhee. The network helps show where Christopher McGhee may publish in the future.
Co-authors
The 15 scholars most cited alongside Christopher McGhee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 Hit paper breakdown → | 2022 | 252 |
| 5 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 6 | 2021 | 213 | |
| 7 | 2021 | 166 | |
| 8 | 2021 | 142 | |
| 9 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 10 | 2022 | 105 | |
| 11 | 2022 | 100 | |
| 12 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 13 | 2021 | 72 | |
| 14 | 2023 | 62 | |
| 15 | 2023 | 60 | |
| 16 | 2022 | 54 | |
| 17 | 2023 | 46 | |
| 18 | 2022 | 45 | |
| 19 | 2021 | 43 | |
| 20 | 2023 | 34 |
About Christopher McGhee
Christopher McGhee is a scholar working on Infectious Diseases, Emergency Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (12 papers), Peripheral Nerve Disorders (4 papers), Nerve Injury and Rehabilitation (3 papers), Cardiac Arrest and Resuscitation (3 papers), Respiratory Support and Mechanisms (3 papers), Sepsis Diagnosis and Treatment (2 papers), Genetic Associations and Epidemiology (2 papers) and Psychometric Methodologies and Testing (1 paper). The work is most often cited by research in Infectious Diseases (1.7k citations), Internal Medicine (49 citations), Pulmonary and Respiratory Medicine (467 citations), Applied Microbiology and Biotechnology (35 citations) and Emergency Medicine (85 citations). Christopher McGhee has collaborated with scholars based in United Kingdom, Netherlands and Vietnam. Frequent co-authors include Maciej Tadeusz Juszczak, Jelle Michiel Zuidam, Liron S. Duraku, Caroline Anna Hundepool, Dominic Power, Mark J.W. van der Oest, Christina Jerosch‐Herold, Caroline Miller, Jeremy Neil Rodrigues and Gráinne Bourke. Their work appears in journals such as JAMA, The Lancet, Intensive Care Medicine, Nature and Intensive Care Medicine Experimental.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.